This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Michigan. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Albert Park in Treating Hearing Loss
Introduction
Albert Park is an innovative inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medicine, particularly in the treatment of congenital cytomegalovirus (cCMV) induced hearing loss. His work is characterized by a commitment to improving health outcomes through scientific research and innovation.
Latest Patents
Albert Park holds a patent for a composition and method for treating congenital cytomegalovirus induced hearing loss. This patent outlines a method that includes administering a composition consisting of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and optionally, a withanolide and/or resveratrol. This innovative approach aims to provide a new avenue for treating a condition that affects many individuals.
Career Highlights
Albert Park is affiliated with the University of Michigan, where he continues to engage in research and development. His work has garnered attention for its potential impact on public health, particularly for those suffering from hearing loss due to cCMV. His dedication to advancing medical science is evident in his research endeavors.
Collaborations
Albert has collaborated with notable colleagues such as Josef M Miller and Glenn E Green. These partnerships have contributed to the depth and breadth of his research, fostering an environment of innovation and discovery.
Conclusion
Albert Park's contributions to the field of medicine, particularly through his patent for treating congenital cytomegalovirus induced hearing loss, highlight his role as a significant inventor. His work exemplifies the intersection of innovation and healthcare, aiming to improve the lives of those affected by hearing loss.